Allogene Therapeutics
ALLO
#6714
Rank
NZ$0.81 B
Marketcap
$3.87
Share price
-7.72%
Change (1 day)
-14.24%
Change (1 year)

Allogene Therapeutics (ALLO) Fails to deliver data

Key failure to deliver metrics for Allogene Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Allogene Therapeutics (ALLO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Allogene Therapeutics (ALLO) - since 2018

Volume in USD (price x number of shares), data since 2018

Allogene Therapeutics (ALLO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$10.13 M-4.38%
2023NZ$10.6 M-67.79%
2022NZ$32.9 M261.68%
2021NZ$9.09 M-84.39%
2020NZ$58.26 M32.36%
2019NZ$44.02 M56.35%
2018NZ$28.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$1.5 MNZ$5.99 M๐Ÿ‡บ๐Ÿ‡ธ USA